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Abstract
Background: Thymopoiesis requires thymocyte-stroma interactions and proteases that promote cell migration by
degrading extracellular matrix and releasing essential cytokines and chemokines. A role for several members of the A
Disintegrin and Metalloprotease (ADAM) family in T cell development has been reported in the past.
Methodology/Principal Findings: Here, we present data indicating that the family member ADAM8 plays a role in thymic T
cell development. We used qrtPCR on FACS sorted thymic subsets together with immunofluorescene to analyze thymic
ADAM8 expression. We found that ADAM8 was expressed in murine thymic stromal cells and at lower levels in thymocytes
where its expression increased as cell matured, suggesting involvement of ADAM8 in thymopoiesis. Further flow cytometry
analysis revealed that ADAM8 deficient mice showed normal development and expansion of immature thymocyte subsets.
There was however an intrathymic accumulation of single positive CD4 and CD8 T cells which was most noticeable in the
late mature T cell subsets. Accumulation of single positive T cells coincided with changes in the thymic architecture
manifest in a decreased cortex/medulla ratio and an increase in medullary epithelial cells as determined by histology and
flow cytometry. The increase in single positive T cells was thymus-intrinsic, independent of progenitor homing to the
thymus or thymic exit rate of mature T cells. Chemotaxis assays revealed that ADAM8 deficiency was associated with
reduced migration of single positive thymocytes towards CCL21.
Conclusions/Significance: Our results show that ADAM8 is involved in T cell maturation in the medulla and suggest a role
for this protease in fine-tuning maturation of thymocytes in the medulla. In contrast to ADAM10 and ADAM17 lack of
ADAM8 appears to have a relatively minor impact on T cell development, which was unexpected given that maturation of
thymocytes is dependent on proper localization and timing of migration.
Citation: Gossens K, Naus S, Holla ¨nder GA, Ziltener HJ (2010) Deficiency of the Metalloproteinase-Disintegrin ADAM8 Is Associated with Thymic Hyper-
Cellularity. PLoS ONE 5(9): e12766. doi:10.1371/journal.pone.0012766
Editor: Derya Unutmaz, New York University, United States of America
Received March 5, 2010; Accepted August 19, 2010; Published September 15, 2010
Copyright:  2010 Gossens et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Supported by Grants MOP-64267 and MOP-77552 (to H.J.Z.) from the Canadian Institutes of Health Research. The funding agency had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hermann@brc.ubc.ca
. These authors contributed equally to this work.
Introduction
Thymic development of T cells is characterized by a series of
complex processes including gene rearrangement, positive and
negative selection for T cell receptor specificity, proliferation and
differentiation (Reviewed in [1]). T cell precursors enter the
thymus from the blood near the cortico-medullary junction,
migrate into the cortex and subsequently undergo four successive
CD4/CD8 double negative (DN) stages: DN1 (CD44
+, CD25
2),
DN2 (CD44
+, CD25
+), DN3 (CD44
2, CD25
+) and pre-double
positive (pre-DP; (CD44
2, CD25
2). At the DN2/DN3 stages, the
b-chain of the TCR is re-arranged. After successful b-chain
selection, DN thymocytes mature into CD4/CD8 double positive
(DP) thymocytes that accumulate in the cortex. Upon rearrange-
ment of the a-chain of the TCR thymocytes undergo positive
selection that is followed by a down-regulation of one of the TCR
co-receptors CD4 or CD8 according to the MHC restriction of the
TCR. Single positive (SP) CD4 or CD8 thymocytes migrate to the
medulla where they undergo negative selection, a process
controlled by medullary thymic epithelial and dendritic cells that
removes cells expressing auto-reactive TCR. Mature self-tolerant
thymocytes leave the thymus for the periphery near the cortico-
medullary junction.
Development and maturation of T cells is associated with
intrathymic migration such that specific developmental stages can
be allocated to particular thymic areas [2,3]. These interactions
are highly dependent on thymocyte-stroma contacts and involve
enzymatic activities of metalloproteinases that enable cells to
migrate on a cellular substrate by remodeling the extracellular
matrix (ECM) and/or by releasing cytokines, chemokines or
growth factors [4,5]. A general function for metalloproteinases in
thymic T cell development was determined by assessing the effect
of a broad-spectrum metalloproteinase inhibitor. In fetal thymic
organ cultures, the inhibitor hindered thymocyte development at
the early DN stages, decreased TCR-b gene rearrangement and
reduced the numbers of DP and SP thymocytes [6]. A role for
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family in thymic T cell development has been reported [7,8,9,10].
The ADAMs form a widely expressed family of membrane-
anchored metalloproteinases with multiple domains including a
zinc-dependent metalloproteinase domain and a disintegrin/
cysteine-rich domain and with functions in physiological processes
such as sperm-egg fusion, neovascularization, and neurogenesis
[11]. Consistent with the above-mentioned findings by Haidl et al.
[6], the expression of a dominant negative form of ADAM10 in
transgenic mice as well as the expression of a catalytically inactive
form of ADAM17 resulted in a partial block at the transition from
the DN to DP stage causing a lower thymic cellularity. Both
ADAM10 and ADAM17 are believed to influence T cell
development via their activity as sheddases for Notch receptor
and Notch ligands [8,9,10]. The prominent expression in murine
purified fetal thymic epithelial cells (TEC) as well as in adult TEC
indicated also a role for ADAM28 in thymic T cell development
[7]. However, it remains elusive whether ADAM28 contributes to
TEC-TEC or TEC-thymocyte interaction via the disintegrin/
cysteine-rich domain or whether it is involved in release of cell
surface proteins like ADAM10 and ADAM17 [7]. The family
member ADAM8/CD156/M2S has previously been detected in
fetal and adult thymi [12,13]. Despite its prominent expression in
most immune cells and tissues particularly under inflammatory
conditions [14,15,16,17,18], the role of ADAM8 in thymus
biology has not yet been examined. Here, we show that ADAM8
is broadly expressed by thymic stromal cells and is detected in
mature thymocytes only at lower levels. Thymi deficient for
ADAM8 expression are hypertrophic due to an increase of SP
thymocytes that results in an altered thymic architecture. A
reduced migration towards CCL21, increased cell proliferation
and a decreased rate of apoptosis are likely causes for the
accumulation of thymocytes in ADAM8 deficient thymi.
Materials and Methods
Ethics Statement
All animal experiments were performed according to institu-
tional guidelines and approved by the Animal Care Committee of
the University of British Columbia.
Mice
C57Bl/6(CD45.2),congenicC57Bl/6(CD45.1)and IL-7Ra-chain
receptor deficient mice were purchased from Jackson Laboratory.
ADAM8 deficient mice backcrossed on C57Bl/6 background [13]
were obtained from Jo ¨rg W. Bartsch (King’s College London, UK).
All mice were bred and maintained in the specific pathogen free (SPF)
animal facility in the Biomedical Research Centre.
Tissue preparation
Single cell suspensions of peripheral lymph nodes and spleens
were prepared by squeezing tissues through a mesh. For bone
marrow suspensions, femurs and tibias were flushed with RPMI,
2% FCS, 2 mM EDTA and cells separated by pipetting. Thymi
were squeezed between two frosted glass slides and washed with
RPMI, 2% FCS, 2 mM EDTA. The thymocyte containing
suspension fractions were filtered and kept for flow cytometry
analysis. For the preparation of thymic stromal cells, thymi were
minced and incubated with Dispase/Collagenase (Roche) as
previously described [19].
Quantitative Real-Time PCR (qrtPCR)
RNA was extracted using TRIzol solution (Invitrogen) and 1 mg
of DNAse-treated total RNA was reverse-transcribed using
Superscript III (Invitrogen). Gene expression for ADAM8 was
quantified using quantitative real time PCR for ADAM8 (forward
59-GTGTGGTTGTGGTCTTGGTG-39, reverse 59-CTTGGG-
TGCCACACTCCT-39) and the endogenous control HPRT
(forward 59-GCTGGTGAAAAGGACCTCT-39, reverse 59-CA-
CAGGACTAGAACACCTGC-39). Reactions were performed
using SYBR green master mix (Bioline). All reactions were run
on a Rotor Gene 6000 real-time PCR system (Corbet Life
Science). Relative mRNA expression was calculated using the
REST software tool [20].
Flow cytometry and cell sorting
Cells were stained in buffer (PBS, 2% FCS, 2 mM EDTA) with
titrated amounts of antibodies: CD3 (145-2C11, Hybridoma
Bank), CD4 (RM4-5, eBioscience), CD8 (53-6.7, eBioscience),
CD11b (M1/70, Hybridoma Bank), CD11c (N418, Hybridoma
Bank), CD19 (ID3, Hybridoma Bank), panNK (DX5, Hybridoma
Bank), cd-TCR (eBioGl3, eBioscience), Gr-1 (RB6-8C5, Hybrid-
oma Bank), Ter119 (Ter119, Hybridoma Bank), CD45.1 (A20,
eBioscience), CD45.2 (104, eBioscience), CD24 (M1/69,
eBioscience), L-Selectin (Mel14, Hybridoma Bank), CD25
(PC61, eBioscience), CD44 (IM7, Hybridoma Bank), CD45 (30-
F11, eBioscience) Sca-1 (D7, BD Biosciences), CD31 (390, BD
Biosciences), CD144 (eBioBV13, eBioscience), MHCII (AF6-
120.1, BioLegend), Ly51 (6C3, BD), EpCAM (G8.8, eBioscience),
UEA-1 (Vector Laboratory), cleaved Caspase-3 (Cell Signaling),
Ki-67 (Santa Cruz Biotechnology). For the detection of lineage
negative cells (Lin
2), suspension cells were stained with an
antibody mix of lineage markers: CD3, CD4, CD8, CD11b,
CD11c, CD19, panNK, cd-TCR, Gr-1, Ter119. For TCR
staining, the Mouse Vb TCR Screening Panel was used according
to manufacturer’s instructions and furthermore a set of antibodies
directed against Va 2 TCR (B20.1), Va 3.2[b, c] TCR (RR3-16),
Va 8.3 TCR (R21.14) and Va 11.1, 11.2[b, d] TCR (RR8-1) (all
BD Biosciences). For intracellular Caspase-3 staining, thymocytes
were cell-surface stained and fixed with 0.5% PFA (10 minutes,
37uC) and subsequently treated with 90% methanol (30 minutes,
4uC) prior to intracellular staining. For Ki-67 detection,
thymocytes were cell-surface stained and then fixed with 70%
ice-cold ethanol over night prior to intracellular staining. CCR7
was detected with CCL19-Fc (eBioscience) according to the
manufacturer’s recommendation.
Where required, a fixed number of reference beads (Interfacial
Dynamics, Invitrogen) were added to each sample to quantify
cellularity. Samples were analyzed on a Calibur or LSRII flow
cytometer and cell sorting was performed on a FACS Vantage or
FACS Aria (all BD Bioscience). Data were analyzed with FlowJo
software (Treestar).
Immunofluorescence
Frozen thymic sections (8 mm) were stored at 280uC until used.
After rehydration in washing buffer (PBS, 0.1% TritonX, 0.05%
Tween20), sections were fixed in acetone (6 minutes) and blocked
with 20% goat serum in washing buffer to reduce unspecific
binding. Sections were incubated with titrated amounts of primary
anti b-galactosidase antibody (ab9361, Abcam), followed by
incubation with antibodies directed against b5t (MBL), MTS10
(kindly provided by Dr. Richard Boyd), ER-TR7 (kindly provided
by Dr. Willem van Ewijk) and CD3 (KT3, Hybridoma Bank),
respectively. Alexa Fluor conjugates (Invitrogen) were used as
secondary reagents. Sections were mounted using Hydromount
(National Diagnostics). Images were acquired using a Zeiss
LSM510 Meta confocal microscope and analyzed using Im-
ageJ1.43k (NIH).
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Thymic sections (20 mm) were fixed (4% PFA/PBS, 15
minutes), stained for 15 minutes in Harris’ Alum Hematoxylin
(Harleco) and subsequently washed for 5 minutes in tap water.
Sections were then stained for 5 minutes with 0.25% Eosin Y
(EMD), 0.5% glacial acetic acid in Ethanol. After consecutive
dehydration in 80%, 90%, 100% ethanol and xylene, sections
were mounted with Permount (Fisher Chemicals). Slides were
analyzed on a dissecting microscope (Leica) and pictures acquired
using QCapture software (QIaging). Image segmentation to
determine cortex/medulla ratio was done by thresholding using
ImageJ1.43k (NIH) software.
Short-term receptivity
Short-term receptivity was determined by i.v. injection of
fluorescent-labeled cells, as previously described [21]. In brief,
40610
6 unfractionated CFSE-labeled bone marrow cells were i.v.
injected into recipients and the numbers of CFSE-labeled cells in
thymi were determined 24 hours later by flow cytometry.
Migration assay
Transwell chambers (5 mm, Costar) were preincubated for
1 hour with media (RPMI supplemented with 0.5% BSA) at 37uC.
Thymocytes (2610
6) in 100 mL media were placed in the upper
wells of the transwell chambers and 600 ml media with or without
chemokine (CCL21, 100 nM) added to the lower chambers. After
90 minutes at 37uC, cells in the lower and upper chambers were
harvested, stained with anti-CD4 and CD8 antibodies and
analyzed by flow cytometry. Where indicated, migration inserts
had been precoated on both sides with Fibronectin (20 mg/mL in
PBS, 2 hours, room temperature, Calbiochem) and had then been
dried before preincubation.
Intrathymic FITC labeling
Intrathymic FITC labeling was performed as previously
reported [22]. 10 ml FITC solution (2 mg/mL in PBS, Sigma
Aldrich) were injected into each thymic lobe of anesthetized mice
using a 1 mL syringe with an attached 28G needle mounted on a
Stepper (Tridak). Thymic labeling efficiency was on average 75%.
Mice were sacrificed 36 hours after injection and the numbers of
labeled CD4 and CD8 cells quantified both in the thymus and
lymph nodes using flow cytometry.
Intrathymic bone marrow injection
Intrathymic bone marrow injection was performed as previously
described [23]. Bone marrow cells (2610
6)i n1 0mL RPMI were
injected into each thymic lobe of anesthetized mice using a 1 mL
syringe with an attached 28G needle mounted on a Stepper
(Tridak). Ten days later, chimerism of bone marrow cells was
assessed by flow cytometry.
Statistics
Data are presented as mean values and error bars as SEM.
Statistical significance was assessed using unpaired, two-tailed,
student’s t test with * p,0.05, ** p,0.01 and *** p,0.001.
Statistics were calculated using SPSS 16.0 for Mac (SPSS Inc.).
Results
ADAM8 is expressed in thymic stromal cells and
thymocytes
It has previously been shown that members of the ADAM
family of metalloproteinases are expressed in adult thymi
[7,8,9,10,12,13] and that ADAM8 is expressed in fetal and adult
thymi [12,13]. We therefore intended to characterize the function
of ADAM8 in the adult murine thymus comparing wild type (wt)
and ADAM8 deficient (ADAM8
2/2) mice.
We used qrtPCR on highly enriched thymic cells (purity .95%)
to detect ADAM8 mRNA expression (Figure 1A–C). ADAM8
mRNA was predominantly expressed in epithelial cells (CD45
2
EpCAM
+) whereas endothelial cells (CD45
2, EpCAM
2, CD31
+)
non-epithelial stromal cells (EpCAM
2, CD45
2, CD31
2) and
hematopoietic cells (CD45
+ EpCAM
2) expressed only 15%, 4%
and 1% thereof, respectively (Figure 1A). ADAM8 RNA
expression levels in thymocytes were lowest in DN cells and
highest in CD8 cells (Figure 1B). In the epithelial cell
compartment, ADAM8 expression was about three times higher
in medullary TEC (mTEC: CD45
2, EpCAM
+, Ly51
lo, UEA-1
hi)
as compared to cortical TEC (cTEC; CD45
2, EpCAM
+, Ly51
hi,
UEA-1
lo) (Figure 1C) confirming published results [12]. mTEC
with a mature phenotype expressing high levels of MHCII
expressed 50% of the ADAM8 mRNA levels of immature mTEC
expressing low levels of MHCII.
The ADAM8
2/2 mice used in our studies contain a b-
galactosidase coding sequence with an internal ribosomal entry site
in the ADAM8 locus, providing an opportunity to analyze
ADAM8 expression in thymic sections. Antibody staining of b-
galactosidase revealed a strong expression in mTEC (Fig. 1E) as
defined by MTS10
+ labeling and weak expression in cTEC
(Fig. 1D) as defined by b5t
+ labeling consistent with our qrtPCR
data. Since the qrtPCR data suggested ADAM8 expression in
non-epithelial cells we stained for ER-TR7 to label an antigen
produced by reticular fibroblasts. Indeed, b-galactosidase was also
detected in ER-TR7
+ cells of the thymic conduit network.
Similarly, b-galactosidase was expressed in CD3
+ cells confirming
our RNA expression profiling (Fig. 1G).
Taken together, qrtPCR and histological analyses identified
ADAM8 to be predominantly expressed in the medulla by mTEC
and, though at lesser degree, by CD8 thymocytes that typically
reside in this compartment.
ADAM8
2/2 thymi are increased in weight and contain
increased numbers of mature thymocytes
Adult ADAM8
2/2 thymi had about a 25% higher thymic
weight when compared to age-matched wt controls (Figure 2A).
This increase in thymic weight was associated with a significant
increase in thymic cellularity (Figure 2B). Furthermore, Hema-
toxylin/Eosin staining and subsequent assessment of the ratio of
thymic cortex/medulla area (C/M) comparing tissue sections of wt
and ADAM8
2/2 mice revealed a reduced C/M ratio for
ADAM8
2/2 thymi (Figure 2C) suggesting an increased medulla
content compared to cortical tissue in ADAM8
2/2 mice.
Similarly, the relative numbers of cTEC as determined by flow
cytometry were comparable for wt and ADAM8
2/2 thymi,
whereas the corresponding values for mTEC were significantly
higher for ADAM8
2/2 mice (Figure 2D,E).
Next, we quantified the thymic subpopulations by flow
cytometry and found comparable cell numbers of early thymic
progenitors (ETP: Lin
2, CD25
2, CD44
+, ckit
+;), all DN subsets
(DN1: Lin
2, CD44
+, CD25
2; DN2: Lin
2, CD44
+, CD25
+; DN3:
Lin
2, CD44
2, CD25
+; pre-DP: Lin
2, CD44
2, CD25
2; Figure 3B)
and DP thymocytes (Figure 3C). In contrast, the cellularities of
CD4 and CD8 thymocytes were significantly increased (p,0.001)
in ADAM8
2/2 compared to wt mice (Figure 3D). This increase
was more pronounced for SP thymocytes of late mature (SP
CD24
low L-Selectin
high) than of the semi mature stages (SP
CD24
high L-Selectin
int; Figure 3E–F). The accumulation of these
ADAM8 Function in Thymopoiesis
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12766Figure 1. ADAM8 is expressed in thymic stromal cells and thymocytes. Relative ADAM8 RNA levels as determined by qrtPCR in (A) total
thymic tissue, thymic hematopoietic cells (CD45
+, EpCAM
2), epithelial cells (CD45
2, EpCAM
+), endothelial cells (CD45
2, EpCAM
2, CD31
+) and other
non-epithelial stromal cells (EpCAM
2, CD45
2, CD31
2), (B) thymic T cell subsets and (C) TEC. FACS sorted cells (.95% purity) were analyzed for
ADAM8 RNA expression using the reference gene HPRT. ADAM8 RNA values are expressed relative to HPRT expression. Data are presented as mean
values and error bars as SEM. Data are from at least two independent experiments (n$3). (D–G) Reporter gene (b-galactosidase) expression in
ADAM8
2/2 thymic sections detected by immunofluorescence. Thymic sections were stained with antibodies directed against b-galactosidase to
reveal potential ADAM8 expression and (D) b5t marking cTEC, (E) MTS10 marking mTEC, (F) ER-TR7 marking fibroblasts and (G) KT-3 marking T cells.
Scales bar 50 mm. Data are from at least four independent experiments (n$4).
doi:10.1371/journal.pone.0012766.g001
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C/M ratio for ADAM8
2/2 thymi.
The accumulation of thymocytes in ADAM8
2/2 mice is
thymus-intrinsic
Generally, an increase in thymocyte numbers and thymic
weight can be caused by higher numbers of T cell progenitors
entering the thymus and/or reduced thymic exit of mature
thymocytes. To determine whether loss of ADAM8 expression
affects the size of the hematopoietic stem cell pool, we determined
absolute numbers of lineage marker negative, Sca-1
+, cKit
+ (LSK)
cells known to contain the hematopoietic stem cell fraction [24] in
the bone marrow of femurs and tibias of wt and ADAM8
2/2
mice. The absolute numbers of LSK cells were similar, suggesting
Figure 2. ADAM8
2/2 thymi have an increased mass and a reduced cortex/medulla ratio associated with a relative increase in mTEC.
(A) Weight and (B) total numbers of thymocytes thymi from age- and gender-matched wt and ADAM
2/2 mice (n=8). (C) Cortex/medulla ratios
examined on Hematoxylin/Eosin stained 20 mm sections of wt and ADAM8
2/2 thymi (each 6 sections of 6 wt or ADAM
2/2 thymi). Frequencies of (D)
cTEC (Ly51
hi, UEA-1
lo) and (E) mTEC (Ly51
lo, UEA-1
hi) in CD45
2, EpCAM
+ thymic epithelial fraction of thymic suspensions obtained by collagenase/
dispase treatment. Data are representative of two independent experiments with at least four mice per group. Data are presented as mean values
and error bars as SEM. *, p,0.05, **, p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0012766.g002
Figure 3. ADAM8
2/2 thymi have increased numbers of thymocytes. Numbers of (A) early thymic progenitors (ETP: DN1 ckit
+), (B) DN
thymocytes, (C) DP thymocytes, (D) CD4 and CD8 thymocytes, (E) semi and late mature CD4 thymocytes and (F) semi and late mature CD8
thymocytes in wt and ADAM8
2/2 thymi. Data are representative of 4 independent experiments with n$4 age- and gender-matched mice per group
in each experiment. Data are presented as mean values and error bars as SEM. *, p,0.05, **, p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0012766.g003
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thymus are identical in both strains (Figure 4A). We next
determined whether lack of ADAM8 altered thymic homing of
cells using a short-term homing assay. For this, CFSE-labeled bone
marrow cells from wt or ADAM8
2/2 donor mice were i.v.
injected into IL-7Ra-chain receptor deficient mice (IL7R
2/2) that
are very receptive for exogenous T cell progenitors due to an early
block in endogenous T cell development [25,26,27]. Twenty-four
hours later, recipients were sacrificed and the numbers of donor-
derived cells in the thymi were determined by flow cytometry. wt
and ADAM8
2/2 donor cells were detected in similar absolute
numbers indicating that an absence of ADAM8 on progenitor cells
does not affect their thymus homing capacities (Figure 4B). We
next analyzed whether thymic export is impaired in ADAM8
2/2
mice. wt and ADAM8
2/2 recipients were intrathymically injected
with FITC solution and their lymph nodes analyzed 36 hours later
for the presence of FITC-labeled T cells [22]. Using labeling
efficiency and thymic cellularity to normalize the data, we found
no difference in the export rates of mature thymocytes when
comparing wt and ADAM8
2/2 mice (Figure 4C).
Collectively, these data argue that neither quantity and quality
of the T cell precursors nor exit of mature thymocytes is affected in
ADAM8
2/2 mice, and hence suggest that thymus intrinsic
processes may be the underlying cause for the increased thymic
cellularity.
ADAM8
2/2 thymocytes have a higher proliferation and a
lower apoptosis rate than wt thymocytes
An increased thymic cellularity can also result from a higher
proliferation and/or reduced apoptosis. We therefore analyzed
thymocytes from wt and ADAM8
2/2 mice for the expression of
Ki-67, a marker for proliferating cells [28], and activated Caspase-
3, an apoptosis marker [29]. Frequencies of Ki-67
hi DN and DP
thymocytes were significantly increased in ADAM8
2/2 mice
suggesting a higher proliferation rate (Figure 5A). Interestingly,
there was also a substantial but not significant reduction in the
frequency of thymocytes staining positively for activated Caspase-3
(Figure 4B). A reduced rate of cell death together with increased
cell proliferation might thus contribute to thymic hyper-cellularity
observed in ADAM8
2/2 mice. The former could be a result of
reduced negative selection whereas the latter of increased positive
selection. However, analysis of the TCR repertoire in lymph nodes
of wt and ADAM8
2/2 mice did not show any skewing in the
usage of the analyzed Va and Vb TCR subfamilies in ADAM8
2/2
Figure 4. Thymic import and export rates are normal in ADAM8
2/2 mice. (A) Numbers of LSK cells in wt and ADAM8
2/2 femurs and tibias.
(B) Total numbers of donor cells per thymus after short-term homing of wt and ADAM8
2/2 bone marrow cells in IL7R
2/2 mice. (C) Numbers of FITC
+
CD4 and CD8 lymph node T cells per 10
6 FITC
+ CD4 and CD8 thymocytes in wt and ADAM8
2/2 mice 36 hours after intrathymic injection of FITC. Data
in (A) and (B) are representative of two independent experiments and data in (C) of three independent experiments with n$4 age- and gender-
matched mice per group in each experiment. Data are presented as mean values and error bars as SEM.
doi:10.1371/journal.pone.0012766.g004
Figure 5. ADAM8
2/2 thymocytes have increased proliferation and reduced apoptosis rates. (A) Frequencies of Ki-67
hi cells in DN, DP
lo
and DP
hi subsets of wt and ADAM8
2/2 thymi. (B) Frequency of Caspase-3
+ thymocytes in wt and ADAM8
2/2 thymi. Data are representative of two
independent experiments with n$4 age- and gender-matched mice per group in each experiment. Data are presented as mean values and error bars
as SEM. *, p,0.05, **, p,0.01.
doi:10.1371/journal.pone.0012766.g005
ADAM8 Function in Thymopoiesis
PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e12766mice and therefore suggests that the thymocyte selection process in
ADAM8
2/2 mice is normal (Figure 6).
Fibronectin-dependentmigrationisreduced inADAM8
2/2
thymocytes
ADAM8 deficiency has previously been associated with reduced
migration of tumor cells [30,31,32] and several types of immune
cells [33]. Since ADAM8 RNA levels were increased in mature
thymocyte subsets, a defect in intrathymic migration to the
medulla could also explain the accumulation of ADAM8
2/2 SP
thymocytes. Thus we tested the ability of ADAM8
2/2 cells to
migrate in a gradient of the chemokine CCL21 that is known to
play a significant role in attracting thymocytes to the medulla
[1,4]. Chemotaxis assays carried out in transwell chambers
revealed that ADAM8 deficiency did not affect the migration of
DN and DP thymocytes. In contrast, ADAM8
2/2 SP thymocytes
showed a trend for lower migration efficiencies towards CCL21
when compared to wt controls (Figure 7A–D). In the presence of
the ECM protein fibronectin however, we observed a statistically
significantdisadvantageinthe migrationefficienciesofADAM8
2/2
SP cells compared to wt controls. Importantly, differences in CCR7
expression between SP thymocytes of wt and ADAM8
2/2 mice
were not detected and thus could not account for differential
responsiveness to its ligand CCL21 (Figure 7E).
Differences in migration and matrix interaction could cause
ADAM8
2/2 thymocytes to occupy certain thymic microenviron-
ments for longer periods of time than thymocytes that express
functional ADAM8 and as a result alter the availability of
intrathymic niche space. To test this hypothesis, wt bone marrow
cells were directly injected into the thymic lobes of wt and
ADAM8
2/2 recipient mice, and donor cells in the respective
recipient thymi quantified 10 days later. Fewer wt donor cells
engrafted in ADAM8
2/2 recipient thymi compared to wt
recipients suggesting that wt donor cells are less competitive in
an ADAM8
2/2 environment (Figure 7F).
Discussion
ADAM8 expression in the thymus has previously been
described [7,8,9,10,12,13]. Here, we comparatively analyzed wt
and ADAM8
2/2 mice to identify in more detail the thymic cell
subsets that express ADAM8 and to identify a potential function
for ADAM8 in T cell development. We show that ADAM8 was
expressed in thymic stromal cells and thymocytes and that
ADAM8 RNA expression was most abundant in mTEC and in
mature thymocytes. We found that absence of ADAM8 was
associated with an accumulation of mature thymocytes and an
increase in medulla size. These findings were unexpected as
deletion of other ADAM family members resulted in a
developmental block at the transition from DN to DP thymocytes
[8,9,10] suggesting that ADAM8 functions in a non-redundant
manner to these family members.
The thymus consists of several functionally different microen-
vironments that express unique sets of genes to support T cell
development [1,12]. It has been shown that the different
microenvironments express different sets of adhesion and matrix
molecules allowing only thymocyte subsets that express the proper
ligands to enter these regions [4]. ADAM8 contains functional
metalloproteinase and disintegrin/cysteine-rich domains with
reported roles in ectodomain shedding [34] and integrin-
disintegrin interaction [35]. ADAM8 expression was strongest in
the medulla; hence this region was most affected in ADAM8
2/2
mice, suggesting that ADAM8 binding partners and/or substrates
modulate access and residence time of cells in the medullary
microenvironment. The specific nature of the binding partners
and/or substrates of ADAM8 however are still unknown.
ADAM8 has functionally been associated with tumor and
immune cell migration [30,31,32,33]. Studies on ADAM8 and
other metalloproteinases revealed that metalloproteinase activity
alone can promote cell attachment, cell outgrowth and cell
migration [36,37,38,39,40] by either direct modification of ECM
components such as fibronectin [36], or from proteolytic release of
cell adhesion molecules that indirectly modify cell attachment and
migration [37,38,39,40]. Both mechanisms might be relevant for
ADAM8-dependent intrathymic cell migration. The fact that
ECM proteins such as fibronectin [41] and collagen I (Bartsch,
personal communication) are proteolytically released by ADAM8
together with our finding that ADAM8
2/2 thymocytes migrated
less efficient through a fibronectin matrix suggests that direct
modulation of matrix components by ADAM8 might be important
for thymocyte migration. ADAM8-dependent intrathymic cell
migration might furthermore be supported by proteolytic release
of thymic cell adhesion molecules, e.g. in an integrin-dependent
way as shown for ADAM10/L1 and [39] and suggested for
ADAM8/Close Homologue of L1[40].
Maturation and expansion of mTEC have been shown to
require direct interaction with mature thymocytes [42,43]. The
observed increase in medulla content in thymi of ADAM8
2/2
mice is thus likely a secondary effect caused by the elevated
number of mature T cells that are present in ADAM8
2/2 thymi.
Based on the observations that an ADAM8 deficient microenvi-
ronment reduced wt T cell progenitor engraftment compared to a
Figure 6. Similar usage of Va and VbTCR chains in wt and ADAM8
2/2 CD4 lymphocytes. Frequencies of CD3
+ CD4
+ lymph node cells
expressing indicated subfamilies of Va or Vb TCR chains determined by flow cytometry. Data are representative of two independent experiments
with n$4 age- and gender-matched mice per group in each experiment. Data are presented as mean values and error bars as SEM.
doi:10.1371/journal.pone.0012766.g006
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thymocyte-intrinsic and extrinsic ADAM8 in the medulla are
necessary for normal thymocyte migration and therefore normal
development. Loss of ADAM8 expression impairs the migration
efficiency of thymocytes in the microenvironment, leading to
longer residence times and finally to accumulation of thymocytes
and limited intrathymic niche space. These increased residence
times might lead to longer thymocyte-TEC interaction providing
the thymocytes with more survival and proliferation signals and
thus explaining the observed increase in thymocyte proliferation
and reduced apoptosis.
ADAM8
2/2 mice do not have an obvious pathologic
phenotype however we recently showed that the lack of ADAM8
renders mice more resistant to induction of experimental asthma
and that this phenotype was in part T cell dependent [33]. We
therefore propose that the role of ADAM8 is to support migration
of immature and mature T cells.
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